A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Whisker Sells One Millionth Robot and Completes Its $10M USA Manufacturing Expansion

The Global Leader in Connected Pet Care Continues Unprecedented Growth as it Maintains Laser Focus on Developing Best-in-Class, Solution-Oriented Pet Products

What To Know

  • “As the global leader in connected pet care and the inventors of the best selling automatic globe-sifting litter box, Litter-Robot,, we take great pride in leading the smart pet tech category to transform cat parenthood for the better, and the sale of our millionth robot is just the start to Whisker doing just that,” said Whisker President and CEO, Jacob Zuppke.
  • Whisker, the international leader in connected pet care for the past 22 years, sold its millionth Robot (Litter-Robot and Feeder-Robot) in December, marking a major milestone for the company as it continues to develop new technologies to solve pain points for today's pet parents.

Whisker, the international leader in connected pet care for the past 22 years, sold its millionth Robot (Litter-Robot and Feeder-Robot) in December, marking a major milestone for the company as it continues to develop new technologies to solve pain points for today’s pet parents. The landmark sale culminates several years of remarkable growth for the brand.

This year alone, the brand launched the latest Litter-Robot iteration, Litter-Robot 4, completed a $10-million investment in U.S. warehouse expansions in Juneau, Wisconsin, and grew its team to over 400 US-based employees with 40+ engineers.

As the leading innovator within the pet care and pet tech space, the Whisker Team proudly designs, engineers and assembles its pet robot appliances in the USA, providing beautiful, solution-oriented products to make pet parenting more enjoyable. Every product is carefully developed and undergoes rigorous testing to meet the high standards of cats and pet parents alike.

The Litter-Robot 4 was meticulously designed by the Whisker Team, taking more than 20 years of product innovation and experience into consideration. Key features of the latest self-cleaning litter box include its patented connected app, health-monitoring technology, and yet another evolution of the brand’s patented litter-sifting mechanism, among additional features that enhance the cat care experience. Since launching in May, Litter-Robot 4 sales have exceeded expectations and generated glowing reviews from press including recognition from TIME Magazine, Wall Street Journal and more. The company’s impressive growth trajectory over the past 5 years was also featured in a profile and daily cover in Forbes in the last month.

“As the global leader in connected pet care and the inventors of the best selling automatic globe-sifting litter box, Litter-Robot,, we take great pride in leading the smart pet tech category to transform cat parenthood for the better, and the sale of our millionth robot is just the start to Whisker doing just that,” said Whisker President and CEO, Jacob Zuppke. “As we reflect on the success of the past several years, including our recent $10M investment to expand our U.S. based manufacturing facility, we’re eager to build on this continued momentum and further enhance the pet and pet parenting experience across the globe.”

This June, Whisker completed its $10 million investment to expand its U.S. manufacturing facility in Juneau, Wisconsin, further demonstrating the brand’s commitment to domestic manufacturing. The opening of the impressive 162,500 square foot facility allowed for the creation of 100+ new jobs, with an expected 200 more in the next two years. The new facility will allow Whisker to continue leading the pet tech industry in both quality and design – guaranteeing Litter-Robot, Feeder-Robot and Litterbox.com customers the best and most ethically-made pet care products here in the USA.

SourceWhisker
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

With this new investment partnership, E Tech Group expects to accelerate organic growth and acquisition to become a top system integrator in North America.
The investment will allow ROM InWest to further distribute its fall detection product globally.
Nawal Ouzren, Sensorion’s Chief Executive Officer, said: “We are thrilled to announce another successful capital raise, securing an additional EUR 15 million to accommodate interest expressed by certain existing investors. This builds on the earlier EUR 50 million financing announced in February 2024, adding up to a total of EUR 100 million raised in less than 9 months. With this new financing, we are well-positioned to accelerate our gene therapy programs, including the progression of SENS-501 through its Phase 1/2 clinical study, Audiogene, and the advancement of our second program, GJB2-GT, towards Clinical Trial Applications submission in H1 2025. The capital increase enables the Company to finance its activities until the end of 2025. We remain deeply thankful for the ongoing support of our shareholders and partners as we strive to make a meaningful difference in the lives of those affected by hearing loss disorders.”
Strategic Investor, Osang Healthcare will partner with Kryptos Biotechnologies for the manufacturing and distribution of the product along with financing.
Proceeds from the financing will advance Obsidian’s lead engineered tumor-infiltrating lymphocyte (TIL) program, OBX-115, in its ongoing trials for patients with melanoma and non-small cell lung cancer (NSCLC). Obsidian Therapeutics is focused on enrolling patients and reaching key clinical and regulatory milestones, as well as manufacturing scale-up ahead of pivotal trial readiness.

By using this website you agree to accept Medical Device News Magazine Privacy Policy